Glastonbury 2023: Rick Astley and The Blossoms play the Smiths…
Which seems like a suitable metaphor for a field test of an experimental algorithm that doesn’t require mealtime bolusing and uses stepcount to mediate how […]
Blog Posts
Novo Nordisk acquisition of Biocorp. A big deal in the Smartpen world?
Novo Nordisk’s acquisition of Biocorp demonstrates how insulin manufacturers are looking to take the next step in optimising insulin delivery, opening up better access to AI techniques for MDI users.
Non-invasive CGM watches. Is this a Dreamcatcher moment?
Another non-invasive CGM in a Smartwatch shows off its wares.
It turned out to be as bad as you’d expect.
Experiments with stepcounts. An n=1 experience
Learning about step counts as an input in AID systems. What does and doesnt work, and what could be better?
Cheap smartwatches with CGM… What do we think?
Trying out a smartwatch with non-invasive glucose monitoring. This isnt the watch you’re looking for….
Everybody’s moving – integrating stepcounts into Open Source Automated Insulin Delivery
Using activity data to change behaviour in AID systems.
Glucagon me… n=1 experiments with microbolusing glucagon part 2: quantifying use
Are two hormones and an algorithm enough? Or is diabetes far more complex than that?
Glucagon me… n=1 experiments with microbolusing Glucagon part 1: setting a baseline
Everyone with type 1 is taught that the big orange plastic box that we’re supposed to keep in the fridge is for emergencies only and […]
Eyecare or iCare? A revolution in the eye screening world.
One of the stands in the Exhibition Hall that stood out was a smaller one, inhabited by a company known as iCare. Perhaps unsurprisingly, their […]
How far are we from fully closed loop? News from ATTD 2023
One of the great things about the ATTD conference is the updates on the technologies that are upcoming, alongside the “What’s already there”. It’s very […]